Financials Surgical Innovations Group plc

Equities

SUN

GB0004016704

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:05 2024-04-26 am EDT 5-day change 1st Jan Change
0.5 GBX 0.00% Intraday chart for Surgical Innovations Group plc 0.00% -16.67%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Capitalization 1 21.91 16.3 15.39 21.92 14.93 4.664 4.664
Enterprise Value (EV) 1 21.53 17.11 13.38 21.06 14.89 5.597 4.797
P/E ratio 31.1 x - - - - - -
Yield - - - - - - -
Capitalization / Revenue 2 x 1.52 x 2.43 x 2.4 x 1.32 x 0.47 x 0.37 x
EV / Revenue 1.96 x 1.59 x 2.11 x 2.31 x 1.31 x 0.47 x 0.39 x
EV / EBITDA 9.11 x 11.8 x -20.3 x 42.1 x 21.3 x 28 x 8.75 x
EV / FCF 18.5 x - - -32.7 x -25.1 x -15.3 x 7.78 x
FCF Yield 5.41% - - -3.06% -3.98% -6.55% 12.9%
Price to Book 1.52 x 1.34 x 1.39 x 2.06 x 1.36 x 0.47 x 0.48 x
Nbr of stocks (in thousands) 782,566 795,316 932,816 932,816 932,816 932,816 932,816
Reference price 2 0.0280 0.0205 0.0165 0.0235 0.0160 0.005000 0.005000
Announcement Date 3/12/19 3/31/20 3/25/21 3/23/22 3/29/23 4/18/24 -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Net sales 1 10.97 10.73 6.329 9.126 11.34 12.01 12.45
EBITDA 1 2.364 1.446 -0.66 0.5 0.7 0.2 0.5485
EBIT 1 0.62 0.54 -1.6 -0.347 0.113 -0.323 -0.1515
Operating Margin 5.65% 5.03% -25.28% -3.8% 1% -2.69% -1.22%
Earnings before Tax (EBT) 0.515 - - - - - -
Net income 0.725 - - - - - -
Net margin 6.61% - - - - - -
EPS 0.000900 - - - - - -
Free Cash Flow 1 1.164 - - -0.645 -0.592 -0.3364 0.6169
FCF margin 10.61% - - -7.07% -5.22% -2.83% 4.96%
FCF Conversion (EBITDA) 49.24% - - - - - 112.47%
FCF Conversion (Net income) 160.55% - - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/12/19 3/31/20 3/25/21 3/23/22 3/29/23 4/18/24 -
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024
Net Debt 1 - 0.81 - - - 0.47 0.13
Net Cash position 1 0.38 - 2.01 0.86 0.04 - -
Leverage (Debt/EBITDA) - 0.5574 x - - - 2.285 x 0.2428 x
Free Cash Flow 1 1.16 - - -0.65 -0.59 -0.34 0.62
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share 2 0.0200 0.0200 0.0100 0.0100 0.0100 0.0100 0.0100
Cash Flow per Share - - - - - - -
Capex 0.49 - - - - - -
Capex / Sales 4.43% - - - - - -
Announcement Date 3/12/19 3/31/20 3/25/21 3/23/22 3/29/23 4/18/24 -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.005 GBP
Average target price
0.02 GBP
Spread / Average Target
+300.00%
Consensus

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. SUN Stock
  4. Financials Surgical Innovations Group plc